Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 25 mg - 55 EUR
  • 100 mg - 220 EUR
  • 250 mg - 440 EUR

Selumetinib

Selumetinib is a potent and selective MEK1/2 ATP-uncompetitive inhibitor with nanomolar IC50 values. It is highly active in both in vitro and in vivo tumor models. This compound is currently being investigated in clinical trials as a cancer drug.

catalogue number: S170
synonyms: AZD6244, ARRY 142886, ARRY-142886, ARRY-886
CAS: 606143-52-6
MW: 457.68 g/mol

References
Mol Cancer Ther. 2007 Jan;6(1):138-46. PMID: 17237274
Clin Cancer Res. 2007 Mar 1;13(5):1576-83. PMID: 17332304
Expert Opin Investig Drugs. 2012 Apr;21(4):531-9. PMID: 22394161